• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MLN4924 抑制 NEDD8-激活酶后细胞蛋白质调节的定量蛋白质组学分析。

Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8-activating enzyme by MLN4924.

机构信息

Discovery, Millennium Pharmaceuticals, Inc., Cambridge, MA 02139, USA.

出版信息

Mol Cell Proteomics. 2011 Nov;10(11):M111.009183. doi: 10.1074/mcp.M111.009183. Epub 2011 Aug 26.

DOI:10.1074/mcp.M111.009183
PMID:21873567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3226404/
Abstract

Cullin-RING ubiquitin ligases (CRLs) are responsible for the ubiquitination of many cellular proteins, thereby targeting them for proteasomal degradation. In most cases the substrates of the CRLs have not been identified, although many of those that are known have cancer relevance. MLN4924, an investigational small molecule that is a potent and selective inhibitor of the Nedd8-activating enzyme (NAE), is currently being explored in Phase I clinical trials. Inhibition of Nedd8-activating enzyme by MLN4924 prevents the conjugation of cullin proteins with NEDD8, resulting in inactivation of the entire family of CRLs. We have performed stable isotope labeling with amino acids in cell culture analysis of A375 melanoma cells treated with MLN4924 to identify new CRL substrates, confidently identifying and quantitating 5122-6012 proteins per time point. Proteins such as MLX, EID1, KLF5, ORC6L, MAGEA6, MORF4L2, MRFAP1, MORF4L1, and TAX1BP1 are rapidly stabilized by MLN4924, suggesting that they are novel CRL substrates. Proteins up-regulated at later times were also identified and siRNA against their corresponding genes were used to evaluate their influence on MLN4924-induced cell death. Thirty-eight proteins were identified as being particularly important for the cytotoxicity of MLN4924. Strikingly, these proteins had roles in cell cycle, DNA damage repair, and ubiquitin transfer. Therefore, the combination of RNAi with stable isotope labeling with amino acids in cell culture provides a paradigm for understanding the mechanism of action of novel agents affecting the ubiquitin proteasome system and a path to identifying mechanistic biomarkers.

摘要

Cullin-RING 泛素连接酶(CRLs)负责许多细胞蛋白的泛素化,从而将它们靶向蛋白酶体降解。在大多数情况下,CRLs 的底物尚未确定,尽管已知的许多底物与癌症有关。MLN4924 是一种正在进行的 I 期临床试验的研究小分子,它是 Nedd8 激活酶(NAE)的有效和选择性抑制剂。MLN4924 抑制 Nedd8 激活酶可防止 Cullin 蛋白与 NEDD8 的缀合,从而使整个 CRL 家族失活。我们对用 MLN4924 处理的 A375 黑色素瘤细胞进行了稳定同位素标记与氨基酸标记的细胞培养分析,以鉴定新的 CRL 底物,每个时间点可自信地鉴定和定量 5122-6012 种蛋白质。MLX、EID1、KLF5、ORC6L、MAGEA6、MORF4L2、MRFAP1、MORF4L1 和 TAX1BP1 等蛋白质被 MLN4924 迅速稳定,表明它们是新的 CRL 底物。还鉴定了在较晚时间上调的蛋白质,并使用针对它们相应基因的 siRNA 来评估它们对 MLN4924 诱导的细胞死亡的影响。鉴定出 38 种蛋白质对 MLN4924 的细胞毒性特别重要。引人注目的是,这些蛋白质在细胞周期、DNA 损伤修复和泛素转移中发挥作用。因此,RNAi 与稳定同位素标记与氨基酸标记的细胞培养相结合,为理解影响泛素蛋白酶体系统的新型药物的作用机制提供了范例,并为鉴定机制性生物标志物提供了途径。

相似文献

1
Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8-activating enzyme by MLN4924.MLN4924 抑制 NEDD8-激活酶后细胞蛋白质调节的定量蛋白质组学分析。
Mol Cell Proteomics. 2011 Nov;10(11):M111.009183. doi: 10.1074/mcp.M111.009183. Epub 2011 Aug 26.
2
Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.Nedd8-激活酶是人类和鼠巨细胞病毒的可药物靶标宿主依赖性因子。
Viruses. 2021 Aug 14;13(8):1610. doi: 10.3390/v13081610.
3
Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen.采用 AlphaScreen 技术对 Nedd8 激活酶抑制剂 MLN4924 的细胞通路抑制作用进行定量分析。
Anal Biochem. 2013 Aug 15;439(2):109-15. doi: 10.1016/j.ab.2013.04.016. Epub 2013 Apr 25.
4
MRFAP1 plays a protective role in neddylation inhibitor MLN4924-mediated gastric cancer cell death.MRFAP1 在 MLN4924 介导的胃癌细胞死亡中发挥保护作用。
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8273-8280. doi: 10.26355/eurrev_201812_16524.
5
Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924).通过NEDD8激活酶抑制剂pevonedistat(MLN4924)靶向黑色素瘤中的蛋白质泛素化机制。
Invest New Drugs. 2017 Feb;35(1):11-25. doi: 10.1007/s10637-016-0398-8. Epub 2016 Oct 25.
6
Suppression of tumor angiogenesis by targeting the protein neddylation pathway.通过靶向蛋白质NEDDylation途径抑制肿瘤血管生成。
Cell Death Dis. 2014 Feb 13;5(2):e1059. doi: 10.1038/cddis.2014.21.
7
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924.新型 DNA 损伤检查点介导 NEDD8 激活酶抑制剂 MLN4924 诱导的细胞死亡。
Cancer Res. 2013 Jan 1;73(1):225-34. doi: 10.1158/0008-5472.CAN-12-1729. Epub 2012 Oct 24.
8
Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.NAE 抑制剂 MLN4924 通过诱导 p21 依赖性衰老来抑制细胞生长的机制研究。
Neoplasia. 2011 Jun;13(6):561-9. doi: 10.1593/neo.11420.
9
Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.Neddylation抑制剂MLN4924抑制人胃癌细胞的生长和迁移。
Sci Rep. 2016 Apr 11;6:24218. doi: 10.1038/srep24218.
10
Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells.NEDD8-激活酶抑制剂 MLN4924 可使 Cullin(CUL)-环 E3 连接酶失活,从而引发癌细胞中的保护性自噬。
Autophagy. 2012 Nov;8(11):1677-9. doi: 10.4161/auto.21484. Epub 2012 Aug 9.

引用本文的文献

1
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615).PEVONEDISTAT 联合化疗治疗复发性或难治性实体瘤儿童患者的 NEDD8 激活酶抑制剂的 I 期研究(ADVL1615)。
Eur J Cancer. 2024 Sep;209:114241. doi: 10.1016/j.ejca.2024.114241. Epub 2024 Aug 2.
2
Diabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila.果蝇中 UCHL1 的缺失会导致糖尿病感觉神经病变和胰岛素抵抗。
Nat Commun. 2024 Jan 11;15(1):468. doi: 10.1038/s41467-024-44747-9.
3
Structural and functional insights into the epigenetic regulator MRG15.MRG15 作为一种表观遗传调控因子的结构与功能见解
Acta Pharmacol Sin. 2024 May;45(5):879-889. doi: 10.1038/s41401-023-01211-6. Epub 2024 Jan 8.
4
MLN4924 Promotes Self-Renewal of Limbal Stem Cells and Ocular Surface Restoration.MLN4924促进角膜缘干细胞自我更新及眼表修复。
J Pers Med. 2023 Feb 21;13(3):379. doi: 10.3390/jpm13030379.
5
Ubiquitination of NKCC2 by the cullin-RING E3 ubiquitin ligase family in the thick ascending limb of the loop of Henle.在 Henle 袢的升支粗段中,cullin-RING E3 泛素连接酶家族对 NKCC2 进行泛素化修饰。
Am J Physiol Renal Physiol. 2023 Mar 1;324(3):F315-F328. doi: 10.1152/ajprenal.00079.2022. Epub 2023 Feb 2.
6
Adaptive exchange sustains cullin-RING ubiquitin ligase networks and proper licensing of DNA replication.适应性交换维持了 Cullin-RING 泛素连接酶网络和 DNA 复制的适当许可。
Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2205608119. doi: 10.1073/pnas.2205608119. Epub 2022 Aug 29.
7
Generation of a CHIP isogenic human iPSC-derived cortical neuron model for functional proteomics.生成一个 CHIP 同基因的人类诱导多能干细胞衍生的皮层神经元功能蛋白质组学模型。
STAR Protoc. 2022 Apr 2;3(2):101247. doi: 10.1016/j.xpro.2022.101247. eCollection 2022 Jun 17.
8
Gene expression profiling reveals the genomic changes caused by MLN4924 and the sensitizing effects of NAPEPLD knockdown in pancreatic cancer.基因表达谱分析揭示了 MLN4924 引起的基因组变化以及 NAPEPLD 敲低对胰腺癌的增敏作用。
Cell Cycle. 2022 Jan;21(2):152-171. doi: 10.1080/15384101.2021.2014254. Epub 2021 Dec 7.
9
Cullin 2-RBX1 E3 ligase and USP2 regulate antithrombin ubiquitination and stability.Cullin 2-RBX1 E3 连接酶和 USP2 调节抗凝血酶的泛素化和稳定性。
FASEB J. 2021 Aug;35(8):e21800. doi: 10.1096/fj.202001146RR.
10
The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma.PEVONEDISTAT 对神经母细胞瘤的抗肿瘤活性。
Int J Mol Sci. 2021 Jun 18;22(12):6565. doi: 10.3390/ijms22126565.

本文引用的文献

1
The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy.NEDD8 缀合途径及其在癌症生物学与治疗中的相关性。
Genes Cancer. 2010 Jul;1(7):708-16. doi: 10.1177/1947601910382898.
2
Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover.NEDD8-激活酶抑制诱导人肿瘤细胞的复制再启动和凋亡,与 CDT1 周转的失调一致。
Cancer Res. 2011 Apr 15;71(8):3042-51. doi: 10.1158/0008-5472.CAN-10-2122. Epub 2011 Apr 12.
3
NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.NEDD8 靶向药物 MLN4924 通过稳定 S 期的 Cdt1 引发 DNA 再复制,从而激活检查点、诱导癌细胞凋亡和衰老。
Cancer Res. 2010 Dec 15;70(24):10310-20. doi: 10.1158/0008-5472.CAN-10-2062.
4
Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.通过系统定量蛋白质组学揭示的 Cullin-RING 泛素连接酶网络的动态变化。
Cell. 2010 Dec 10;143(6):951-65. doi: 10.1016/j.cell.2010.11.017.
5
Cullins and cancer.卡林蛋白与癌症
Genes Cancer. 2010 Jul;1(7):690-9. doi: 10.1177/1947601910382899.
6
Accurate quantification of more than 4000 mouse tissue proteins reveals minimal proteome changes during aging.准确量化 4000 多种小鼠组织蛋白,揭示衰老过程中最小的蛋白质组变化。
Mol Cell Proteomics. 2011 Feb;10(2):M110.004523. doi: 10.1074/mcp.M110.004523. Epub 2010 Nov 3.
7
A novel strategy to isolate ubiquitin conjugates reveals wide role for ubiquitination during neural development.一种分离泛素缀合物的新策略揭示了泛素化在神经发育过程中的广泛作用。
Mol Cell Proteomics. 2011 May;10(5):M110.002188. doi: 10.1074/mcp.M110.002188. Epub 2010 Sep 22.
8
Quantitative proteomic analyses of influenza virus-infected cultured human lung cells.流感病毒感染培养的人肺细胞的定量蛋白质组学分析。
J Virol. 2010 Oct;84(20):10888-906. doi: 10.1128/JVI.00431-10. Epub 2010 Aug 11.
9
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.MLN4924,一种 NEDD8 激活酶抑制剂,在弥漫性大 B 细胞淋巴瘤模型中具有活性:治疗 NF-κB 依赖性淋巴瘤的原理。
Blood. 2010 Sep 2;116(9):1515-23. doi: 10.1182/blood-2010-03-272567. Epub 2010 Jun 4.
10
Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib.全基因组 siRNA 筛选筛选蛋白酶体抑制剂硼替佐米诱导细胞死亡的调节剂。
Cancer Res. 2010 Jun 1;70(11):4318-26. doi: 10.1158/0008-5472.CAN-09-4428. Epub 2010 May 11.